Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

By G. Anderson, M. Limacher, A. Assaf, T. Bassford, S. Beresford, H. Black, D. Bonds, R. Brunner, R. Brzyski, B. Caan and 34 more. 2004

1,265 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Genetics, Obstetrics and Gynecology

View Paper: https://www.semanticscholar.org/paper/c1200159132b629d8cce0bf7f124dd73d78c801e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Victor M. Montori

Citations in the corpus

• European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2018, background): “In hysterectomized women receiving conjugates oestrogen alone, there was also an increase in stroke, but not of CHD and breast cancer, suggesting a deleterious effect of medroxyprogesterone acetate [281].”
• Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. (2015, background): “(MPA) in women with a uterus (18), was associated with risks disproportionate to preventive benefits (17, 18).”